Aveanna Healthcare (AVAH) financial statements
Aveanna Healthcare reported revenue of $2.4B in fiscal 2025, up 9.9% a year over 6 years.
Net income was $225M and the operating margin 10.5%, against 2.8% in 2019.
Free cash flow was $118M.
The diluted share count rose 57% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Aveanna Healthcare's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.7B | $1.8B | $1.9B | $2.0B | $2.4B |
| Cost of revenue | $965M | $1.0B | $1.1B | $1.2B | $1.3B | $1.4B | $1.6B |
| Gross profit | $419M | $455M | $542M | $553M | $595M | $636M | $810M |
| Selling, general and admin | $228M | $241M | $297M | $357M | $361M | $353M | $374M |
| Operating income | $39M | -$3M | -$36M | -$642M | $8M | $140M | $256M |
| Interest expense | $92M | $83M | $69M | $108M | $153M | $157M | $140M |
| Pre-tax income | -$75M | -$52M | -$114M | -$664M | -$139M | $5M | $107M |
| Income tax | $1M | $5M | $3M | -$2M | -$4M | $16M | -$118M |
| Net income | -$77M | -$57M | -$117M | -$662M | -$135M | -$11M | $225M |
| EPS (diluted) | -$0.56 | -$0.40 | -$0.69 | -$3.57 | -$0.71 | -$0.06 | $1.05 |
| Diluted shares | 137M | 141M | 171M | 186M | 190M | 193M | 215M |
| Gross margin | 30.3% | 30.4% | 32.3% | 30.9% | 31.4% | 31.4% | 33.3% |
| Operating margin | 2.8% | -0.2% | -2.2% | -35.9% | 0.4% | 6.9% | 10.5% |
| Net margin | -5.5% | -3.8% | -7.0% | -37.0% | -7.1% | -0.5% | 9.2% |
Balance sheet
Fiscal years, from Aveanna Healthcare's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | — | $137M | $30M | $19M | $44M | $84M | $193M |
| Receivables | — | $173M | $219M | $221M | $237M | $265M | $313M |
| Total current assets | — | $341M | $279M | $270M | $315M | $393M | $560M |
| Property, plant and equipment | — | $33M | $31M | $23M | $21M | $17M | $17M |
| Goodwill | $1.2B | $1.3B | $1.8B | $1.2B | $1.1B | $1.1B | $1.1B |
| Total assets | — | $1.8B | $2.3B | $1.7B | $1.6B | $1.7B | $2.0B |
| Total current liabilities | — | $260M | $345M | $326M | $355M | $402M | $424M |
| Long-term debt | — | $1.2B | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B |
| Total liabilities | — | $1.6B | $1.7B | $1.7B | $1.7B | $1.8B | $1.8B |
| Shareholders' equity | $270M | $265M | $636M | -$6M | -$130M | -$124M | $194M |
| Net debt | — | $1.0B | $1.2B | $1.3B | $1.2B | $1.2B | $1.1B |
Cash flow
Fiscal years, from Aveanna Healthcare's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9M | $117M | -$11M | -$48M | $23M | $33M | $126M |
| Capital spending | $17M | $15M | $16M | $12M | $6M | $6M | $7M |
| Free cash flow | -$25M | $101M | -$27M | -$60M | $17M | $26M | $118M |
| Stock-based compensation | $2M | $3M | $14M | $16M | $13M | $17M | $25M |
| Free cash flow margin | -1.8% | 6.8% | -1.6% | -3.4% | 0.9% | 1.3% | 4.9% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AVAH.
Open AVAH in InvestinglyQuestions
What was Aveanna Healthcare's revenue in 2025?
$2.4B in fiscal 2025, from its 10-K filing.
How much free cash flow does Aveanna Healthcare generate?
$118M in fiscal 2025 (operating cash flow minus capital spending).
From Aveanna Healthcare's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.